Aquilo Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2022
         Q4  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $6.81M | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $3.94M | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $45.9M | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $79.5M | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $84M | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $53.5M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $56.4M | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $76.2M | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q3  | $50.2M | Buy | 
         | 
    |||||
| 
        
          
      
        2020
         Q2  | $26.3M | Buy | 
         | 
    |||||
| 
        
          
      
        2020
         Q1  | $14.7M | Buy | 
         | 
    |||||
| 
        
          
      
        2019
         Q4  | $11.1M | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q3  | $12.2M | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q2  | $13.3M | Buy | 
         | 
    |||||
| 
        
          
      
        2019
         Q1  | $13.5M | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q4  | $6.35M | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q3  | $8.4M | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q2  | $6.11M | Buy | 
         |